#ESCCongress – RCT: In patients who underwent PCI at high blee | Cardiology
#ESCCongress– RCT: In patients who underwent PCI at high bleeding risk, 1 month of dual antiplatelet therapy was noninferior to the continuation of dual therapy for at least 2 additional months and resulted in a lower incidence of bleeding events.
